ISLAND PHARMACEUTICALS LIMITED

19.2%

43.5¢

Market Cap $110.3M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Latest Threads

Tag

Subject

ILA

Ann: FDA Meeting request granted

20/09/25

2.9K

20/09/25

Last post arsenal1954

2.9K

ILA

Chart

2 3

20/09/25

148

41K

20/09/25

Last post Beaza79

148

41K

ILA

Ann: Investor webinar

19/09/25

2.0K

19/09/25

Last post The Knightrider

2.0K

ILA

Ann: Investor presentation - Galidesivir update

18/09/25

3.8K

18/09/25

Last post fallingup

3.8K

ILA

Ann: FDA meeting request lodged for Galidesivir

16/09/25

6.8K

16/09/25

Last post ma420

6.8K

ILA

Ann: Application for quotation of securities - ILA

09/09/25

750

09/09/25

Last post BillyHill

750

ILA

Ann: Cleansing Notice

09/09/25

195

09/09/25

Last post

ASX News

195

ILA

ILA - Media coverage

05/09/25

106

35K

05/09/25

Last post ma420

106

35K

See All Discussions

Timeline

FDA Meeting request granted
19 Sep 09:29	Share

Investor webinar
18 Sep 09:06	Share

Investor presentation - Galidesivir update
17 Sep 09:53	Share

Cleansing Notice
09 Sep 08:29	Share

Application for quotation of securities - ILA
09 Sep 08:29	Share

Letter to Shareholders, Notice of AGM & Proxy Form
05 Sep 09:44	Share

FDA meeting request lodged for Galidesivir
01 Sep 08:45	Share

Annual Report to shareholders (incl auditor independence)
29 Aug 10:09	Share

Appendix 4G and Corporate Governance Statement
29 Aug 08:27	Share

Annual Report to shareholders
29 Aug 08:25	Share

Preliminary Final Report
29 Aug 08:22	Share

Change in substantial holding
15 Aug 10:07	Share

Date of AGM & Closing Date for Director Nominations
14 Aug 12:08	Share

Presentation to the Third Annual Dengue Endgame Summit
14 Aug 09:32	Share

Options exercise from existing substantial shareholder
11 Aug 09:55	Share

Cleansing Notice
11 Aug 09:52	Share

Application for quotation of securities - ILA
11 Aug 09:51	Share

Completion of Galidesivir transaction
31 Jul 08:22	Share

Investor Presentation and investor roadshow
28 Jul 13:22	Share

Change of Director's Interest Notice - JC
25 Jul 08:36	Share

Quarterly Appendix 4C and Activities Report
24 Jul 09:00	Share

Change in substantial holding
17 Jul 10:33	Share

Options exercise from existing substantial shareholder
17 Jul 10:32	Share

Cleansing Notice
16 Jul 08:29	Share

Application for quotation of securities - ILA
16 Jul 08:23	Share

Investor presentation
09 Jul 09:22	Share

Portfolio expansion achieved with acquisition of Galidesivir
09 Jul 09:16	Share

Trading Halt
07 Jul 09:33	Share

Notification of cessation of securities - ILA
04 Jul 09:00	Share

Cancel - Notification of cessation of securities - ILA
04 Jul 09:00	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 43.5¢		Change 0.070(19.2%)		Mkt cap ! $110.3M

Open	High	Low	Value	Volume
36.5¢	46.0¢	35.5¢	$1.221M	2.977M

Buyers (Bids)

No.	Vol.	Price($)
2	3939	43.5¢

Sellers (Offers)

Price($)	Vol.	No.
45.0¢	12200	2

View Market Depth

No.	Vol.	Price($)
1	1000	0.435
1	4719	0.430
2	9648	0.420
3	16267	0.400
1	2000	0.395

Price($)	Vol.	No.
0.450	3700	1
0.460	34750	1
0.470	1550	1
0.500	4000	1
0.510	59000	1

Last trade - 16.10pm 19/09/2025 (20 minute delay)

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Island Pharmaceuticals (ASX:ILA) receives FDA feedback on clinical trial application

01 Feb 2023 15:53 (AEDT)

Latest Articles

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.

Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy

Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug.

Island Pharmaceuticals (ASX:ILA) receives $1.96m grant to support ISLA-101 clinical development

Island Pharmaceuticals (ASX:ILA) has received a $1.96 million grant to support phase 2a human clinical trials of its ISLA-101 dengue fever treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News